Vaidya Sane Ayurved Laboratories Limited

NSEI:MADHAVBAUG Stock Report

Market Cap: ₹1.5b

Vaidya Sane Ayurved Laboratories Management

Management criteria checks 2/4

Vaidya Sane Ayurved Laboratories' CEO is Rohit Sane, appointed in Feb 2025, has a tenure of less than a year. total yearly compensation is ₹6.00M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 66.29% of the company’s shares, worth ₹975.70M. The average tenure of the management team and the board of directors is 0.8 years and 3.7 years respectively.

Key information

Rohit Sane

Chief executive officer

₹6.0m

Total compensation

CEO salary percentage100.0%
CEO tenureless than a year
CEO ownership66.3%
Management average tenureless than a year
Board average tenure3.7yrs

Recent management updates

Recent updates

Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues

Nov 08
Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues

Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?

Aug 25
Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?

Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Jun 11
Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

CEO Compensation Analysis

How has Rohit Sane's remuneration changed compared to Vaidya Sane Ayurved Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹41m

Jun 30 2024n/an/a

₹30m

Mar 31 2024₹6m₹6m

₹20m

Dec 31 2023n/an/a

₹26m

Sep 30 2023n/an/a

₹33m

Jun 30 2023n/an/a

₹41m

Mar 31 2023₹6m₹6m

₹48m

Dec 31 2022n/an/a

₹48m

Sep 30 2022n/an/a

₹48m

Jun 30 2022n/an/a

₹42m

Mar 31 2022₹2m₹2m

₹35m

Compensation vs Market: Rohit's total compensation ($USD70.27K) is above average for companies of similar size in the Indian market ($USD42.06K).

Compensation vs Earnings: Rohit's compensation has been consistent with company performance over the past year.

CEO

Rohit Sane (47 yo)

less than a year

Tenure

₹6,000,000

Compensation

Dr. Rohit Madhav Sane serves as Chief Executive Officer at Vaidya Sane Ayurved Laboratories Limited since February 13, 2025. He is Managing Director at Vaidya Sane Ayurved Laboratories Private Limited and...

Leadership Team

NamePositionTenureCompensationOwnership
Rohit Sane
MD, CEO & Directorless than a year₹6.00m66.29%
₹ 975.7m
Vidyut Ghag
Chief Administrative Officer & Whole time Directorno data₹1.71mno data
Gurudatta Amin
Chief Medical Officerno data₹2.71mno data
Yogesh Walawalkar
Chief Strategy Officerno data₹4.50mno data
Narendra Pawar
Chief Financial Officer1yrno datano data
Rahul Mandole
Head of Researchno datano datano data
Sapna Vaishnav
Company Secretary & Compliance Officerless than a yearno datano data
Nilesh Kulthe
Zonal Medical Headno datano datano data
Pravin Ghadigoankar
Head of Medical Operationsno datano datano data
Clifford Quadros
Head of Digital Marketingno datano datano data
Sushant Kulkarni
Regional Head of Central & Western Mumbaino datano datano data

0.8yrs

Average Tenure

41yo

Average Age

Experienced Management: MADHAVBAUG's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Rohit Sane
MD, CEO & Director20.2yrs₹6.00m66.29%
₹ 975.7m
Vidyut Ghag
Chief Administrative Officer & Whole time Director3.7yrs₹1.71mno data
Ratnakar Rai
Non-Executive Independent Director3.7yrs₹280.00kno data
Mahesh Kshirsagar
Non-Executive & Independent Director3.7yrs₹280.00kno data
Sushrut Dambal
Non-Executive & Independent Director3.5yrs₹280.00kno data

3.7yrs

Average Tenure

47yo

Average Age

Experienced Board: MADHAVBAUG's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 19:49
End of Day Share Price 2025/05/09 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vaidya Sane Ayurved Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.